研報掘金丨浙商證券:新華保險業績及股東回報全面超預期,維持“買入”評級
浙商證券研報指出,2024年新華保險(601336.SH)歸母淨利潤262.29億元,同比大幅增長201.1%,公司2024年全年分紅總額達78.93億元,同比大增197.6%,分紅率30.1%,公司業績及股東回報全面超預期。展望未來,新華全面革新隊伍發展體系,通過“XIN 一代”計劃推動代理人隊伍專業化改革,隊伍產能有望繼續提升,銀保渠道繼續放量,價值貢獻進一步凸顯,多措並舉下,有望驅動新華NBV的進一步增長。新華積極推進“以客戶爲中心”的戰略轉型,加快專業化、市場化、體系化改革落實落地,構建新的增長動能,公司在權益投資方面表現優秀,資產端高彈性,貝塔屬性強。維持目標價62.58元,對應2025年PEV0.73倍,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.